CC
BPMC

Corton Capital’s Blueprint Medicines BPMC Stock Holding History

Corton Capital’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,107
Closed -$271K – 202
2024
Q4 		$271K Buy
3,107
+49
+2% +$4.49K 0.16% 144
2024
Q3 		$283K Buy
+3,058
New +$304K 0.14% 214
2024
Q1 		– Sell
-2,501
Closed -$231K – 520
2023
Q4 		$231K Sell
2,501
-4,333
-63% -$281K 0.07% 417
2023
Q3 		$343K Buy
6,834
+2,103
+44% +$112K 0.17% 162
2023
Q2 		$299K Sell
4,731
-167
-3% -$9.08K 0.14% 215
2023
Q1 		$220K Buy
4,898
+252
+5% +$11.4K 0.15% 217
2022
Q4 		$204K Buy
+4,646
New +$223K 0.17% 219

Other funds holding BPMC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Corton Capital's BPMC Position: Q1 2025 in Review

Corton Capital sold out of Blueprint Medicines (BPMC) in Q1 2025, closing a stake of 3,107 shares — an estimated $271K sold.

Corton Capital first reported a position in BPMC in Q4 2022 and held it in 7 quarters. The position peaked at $343K in Q3 2023. 352 funds tracked by Wall St. Rank hold BPMC as of Q1 2025.

  • Corton Capital reported no remaining Blueprint Medicines position as of Q1 2025 after selling out during the quarter.
  • Corton Capital sold 3,107 Blueprint Medicines shares in Q1 2025, an estimated $271K.
  • Corton Capital first reported a position in Blueprint Medicines in Q4 2022 and held it in 7 quarters.
  • Corton Capital's Blueprint Medicines position peaked at $343K in Q3 2023.
  • 352 funds tracked by Wall St. Rank held Blueprint Medicines as of Q1 2025.

Based on Corton Capital's 13F filing for Q1 2025, filed 7 May 2025.